Ind-Swift

INDSWFTLTD03 May 2024

Pharmaceuticals

₹

-0.49 (-1.96%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Ind-Swift

Ind-Swift

Pharmaceuticals

INDSWFTLTD03 May 2024

₹

-0.49 (-1.96%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
24-Mar-2005	S	Board has approved the stock split i.e. sub-division of every equity shares of face value of Rs 10/- each into 5 shares of face value of Rs 2/- each and consequential changes in Memorandum & Articles of Associations of the Company.Further the Company has informed that it has been decided to convene an Extra Ordinary General Meeting of the shareholders of the Company on April 20, 2005 to obtain their approvals. Members of the Exchange are hereby informed that, Ind-Swift Ltd. has fixed the Record Date for the purpose of sub division. SUB- DIVIDED PAID-UP VALUE SUB-DIVIDED PAID-UP VALUE W.E.F. Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into Five equity shares of Rs.2/- each.Rs.2/- 29/04/2005 The auction in the equity shares of Ind-Swift Ltd in Dematerialised Securities - Rolling Settlement Segment on 29/04/2005 , 02/05/2005 & 03/05/2005 will be conducted as per face value of Rs.10/- each. Members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates. The scrip will be No Delivery from 29/04/2005 (DR-022/2005-2006) to 05/05/2005 (DR-026/2005-2006). Note: - i. Members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 29.04.2005. ii. ISIN No. INE788B01010 of Rs.10/- paid up will be discontinued w.e.f. 29.04.2005 and the new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice. (As per BSE Notice dated on 22/04/2005)	06-May-2005
02-Sep-2011	D	Ind-Swift Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2011, inter alia, have recommended dividend @ 1% on Cumulative Redeemable preference shares (Rs. 1/- per share) and 20% on Equity shares (Rs. 0.40 per share).	21-Sep-2011
07-Sep-2010	D	Ind-Swift Limited has informed the Exchange that the following decisions have been taken by the Board of Directors in its meeting held on September 06, 2010: The Share Transfer Books of the company shall remain closed from September 28, 2010 to September 30, 2010 (both days inclusive) for the purpose of Annual General Meeting and to ascertain the names of shareholders who shall be entitled to receive dividend declared @ 20% on equity shares (i.e. Rs.0.40 per share). Ind-Swift Limited has informed the Exchange that the Board of Directors of the company in their meeting held on September 6, 2010 has declared dividend @ 20% on equity shares (i.e. Rs.0.40 per share).	24-Sep-2010
21-Aug-2009	D	Ind Swift Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 21, 2009, inter alia, has recommended a dividend of 20% on 37178370 equity shares of Re 2/- each.	17-Sep-2009
25-Aug-2008	D	Ind Swift Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 23, 2008, inter alia, has recommended a dividend of 20% on 37178370 equity shares of Rs 2/- each.	19-Sep-2008
03-Sep-2007	D	Ind Swift Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 03, 2007, inter alia, has recommended a dividend of 20% on equity shares of Rs 2/- each.	21-Sep-2007
05-Sep-2006	D	20% Dividend	28-Sep-2006
01-May-2006	D	20% Dividend	22-Sep-2005
02-May-2024	BC	IND-SWIFT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve the Audited Financial Results of the Company for	14-May-2024
31-Aug-2023	BC	OUTCOME OF BOARD MEETING HELD ON 31ST AUGUST, 2023 Outcome of Board Meeting dated 30.03.2024. (As Per BSE Announcement Dated on 30/03/2024)	01-Apr-2024
30-Mar-2024	BC	Outcome of Board Meeting dated 30.03.2024.	31-Mar-2024
30-Mar-2024	BC	Outcome of Board Meeting dated 30.03.2024.	30-Mar-2024
15-Feb-2024	BC	Intimation regarding Postal Ballot notice. Outcome of postal ballot whereby the ordinary resolution has been passed by the shareholders with requisite majority. Scrutinizers report for postal b	17-Mar-2024

Announcement Date02-Sep-2011

Ex Dividend Date21-Sep-2011

Dividend(%)20

Announcement Date07-Sep-2010

Ex Dividend Date24-Sep-2010

Dividend(%)20

Announcement Date21-Aug-2009

Ex Dividend Date17-Sep-2009

Dividend(%)20

Announcement Date25-Aug-2008

Ex Dividend Date19-Sep-2008

Dividend(%)20

Announcement Date03-Sep-2007

Ex Dividend Date21-Sep-2007

Dividend(%)20

Announcement Date05-Sep-2006

Ex Dividend Date28-Sep-2006

Dividend(%)20

Announcement Date01-May-2006

Ex Dividend Date22-Sep-2005

Dividend(%)20

No Rights has been declared by INDSWFTLTD

Book Closure

Record Date	Split Date	Purpose
14-May-2024	-	IND-SWIFT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve the Audited Financial Results of the Company for
01-Apr-2024	-	OUTCOME OF BOARD MEETING HELD ON 31ST AUGUST, 2023 Outcome of Board Meeting dated 30.03.2024. (As Per BSE Announcement Dated on 30/03/2024)
31-Mar-2024	-	Outcome of Board Meeting dated 30.03.2024.
30-Mar-2024	-	Outcome of Board Meeting dated 30.03.2024.
17-Mar-2024	01 Jan'1900	Intimation regarding Postal Ballot notice. Outcome of postal ballot whereby the ordinary resolution has been passed by the shareholders with requisite majority. Scrutinizers report for postal b

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Ind-Swift Ltd ₹24.46(-0.49/-1.96%)	24.46	-0.49	135.14	186.78	0.00	-0.19
Astrazeneca Pharma India Ltd ₹5,440.00(+106.15/1.99%)	5,440.00	+106.15	13,334.63	67.79	83.60	20.36
Bliss GVS Pharma Ltd ₹119.00(-10.20/-7.89%)	119.00	-10.20	1,352.61	67.42	19.82	1.38
Cipla Ltd ₹1,424.25(+4.70/0.33%)	1,424.25	+4.70	114,613.75	54.95	34.85	4.43
Amrutanjan Health Care Ltd ₹776.40(-10.20/-1.30%)	776.40	-10.20	2,274.11	29.81	51.68	8.68
Abbott India Ltd ₹26,154.10(-450.25/-1.69%)	26,154.10	-450.25	56,534.24	18.89	49.35	18.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	102.56	115.92	148.54	105.88	106.59	103.82
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	102.56	115.92	148.54	105.88	106.59	103.82
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.62	3.15	5.63	66.86	3.20	0.87
Total Income	105.18	119.07	154.17	172.74	109.79	104.68
Total Expenditure	98.07	104.78	130.14	97.92	88.69	92.76
PBIDT	7.11	14.29	24.03	74.81	21.10	11.93
Interest	15.30	18.26	14.95	14.48	14.84	15.38
PBDT	-8.19	-3.97	9.08	60.33	6.26	-3.46
Depreciation	6.78	6.73	6.72	7.24	7.29	7.13
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-14.97	-10.71	2.36	53.10	-1.03	-10.59
Extra-ordinary Items	0.00	0.00	0.00	60.58	0.00	0.00
Adjusted Profit After Extra-ordinary item	-14.97	-10.71	2.36	-7.48	-1.03	-10.59

EPS (Unit Curr.)	-2.76	-1.98	0.44	9.80	-0.19	-1.96
EPS (Adj) (Unit Curr.)	-2.76	-1.98	0.44	9.80	-0.19	-1.96
Calculated EPS (Unit Curr.)	-2.76	-1.98	0.44	9.80	-0.19	-1.96
Calculated EPS (Adj) (Unit Curr.)	-2.76	-1.98	0.44	9.80	-0.19	-1.96
Calculated EPS (Ann.) (Unit Curr.)	-11.05	-7.91	1.74	39.21	-0.76	-7.82
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-11.05	-7.91	1.74	39.21	-0.76	-7.82
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.83	10.83	10.83	10.83	10.83	10.83
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	6.93	12.33	16.18	70.66	19.80	11.49
PBDTM(%)	-7.99	-3.42	6.11	56.98	5.87	-3.33
PATM(%)	-14.60	-9.24	1.59	50.15	-0.97	-10.20

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	102.56	115.92	148.54	105.88	106.59	103.82
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	102.56	115.92	148.54	105.88	106.59	103.82
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.62	3.15	5.63	66.86	3.20	0.87
Total Income	105.18	119.07	154.17	172.74	109.79	104.68
Total Expenditure	98.07	104.78	130.14	97.92	88.69	92.76
PBIDT	7.11	14.29	24.03	74.81	21.10	11.93
Interest	15.30	18.26	14.95	14.48	14.84	15.38
PBDT	-8.19	-3.97	9.08	60.33	6.26	-3.46
Depreciation	6.78	6.73	6.72	7.24	7.29	7.13
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-14.97	-10.71	2.36	53.10	-1.03	-10.59
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-14.97	-10.71	2.36	53.10	-1.03	-10.59

Extra-ordinary Items	0.00	0.00	0.00	60.58	0.00	0.00
Adjusted Profit After Extra-ordinary item	-14.97	-10.71	2.36	-7.48	-1.03	-10.59

EPS (Unit Curr.)	-2.76	-1.98	0.44	9.80	-0.19	-1.96
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.83	10.83	10.83	10.83	10.83	10.83

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	6.93	12.33	16.18	70.66	19.80	11.49
PBDTM(%)	-7.99	-3.42	6.11	56.98	5.87	-3.33
PATM(%)	-14.60	-9.24	1.59	50.15	-0.97	-10.20

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	25.03	25.03	25.03	25.03	25.03	25.03
Reserves Total	-715.53	-731.15	-706.00	-723.95	-687.57	-690.20
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-690.50	-706.12	-680.97	-698.92	-662.54	-665.17
Secured Loans	871.66	966.71	1003.55	990.45	979.06	1010.68
Unsecured Loans	106.75	54.75	4.79	12.34	16.64	30.44
Total Debt	978.41	1021.46	1008.34	1002.79	995.70	1041.12
Total Liabilities	287.91	315.34	327.37	303.87	333.16	375.95
APPLICATION OF FUNDS :
Gross Block	637.40	630.11	607.40	601.47	589.92	576.33
Less : Accumulated Depreciation	420.94	394.61	363.39	331.81	299.37	265.65
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	216.46	235.50	244.01	269.66	290.55	310.68
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	29.73	9.00	13.06	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	53.73	64.35	70.31	24.06	41.26	43.91
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	89.35	69.58	62.85	52.41	49.00	45.44
Sundry Debtors	104.58	90.62	107.95	94.17	75.56	83.50
Cash and Bank	13.33	16.18	28.99	16.76	19.72	3.68
Loans and Advances	66.12	66.06	65.39	65.32	49.23	53.49
Total Current Assets	273.38	242.44	265.17	228.65	193.51	186.11
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	345.23	300.48	327.79	281.54	250.64	224.11
Provisions	1.60	1.19	0.00	0.00	0.00	0.00
Total Current Liabilities	346.83	301.67	327.79	281.54	250.64	224.11
Net Current Assets	-73.44	-59.23	-62.61	-52.89	-57.13	-38.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	226.48	249.63	264.77	240.83	274.69	316.59
Contingent Liabilities	0.38	0.25	0.40	75.37	77.74	35.31

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	16.18	28.99	16.76	19.72	3.68
Net Cash from Operating Activities	73.05	50.20	83.19	34.60	42.79
Net Cash Used In Investing Activities	-29.35	-18.42	-16.71	-11.35	-13.71
Net Cash Used In Financing Activities	-46.56	-44.60	-54.25	-26.20	-13.03
Net Inc./Dec In Cash And Cash Equivalents	-2.85	-12.81	12.23	-2.96	16.05
Cash And Cash Equivalents At End Of The Year	13.33	16.18	28.99	16.76	19.72

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

55.58%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

44.42%

**Promoter pledged shareholding 55.58%

About Ind-Swift Ltd

Ind-Swift Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 135.14 crores. It has reported a sales of Rs. 102.56 crores and a net profit of Rs. -14.97 crores for the quarter ended December 2018. The company management includes S R Mehta, G Munjal,S R Mehta,V R Mehta,Himanshu Jain,N R Munjal,Rishav Mehta,S P Sharma,V K Arora,Subhash Chander Galhotra,Anoop Michra,Jagvir Singh Ahluwalia,Ginny Uppal,Bhupinder Singh (Ind-Swift Ltd) among others.

Chairman

S R Mehta

Registered office

781 Industrial Area Phase-II,Ram Darbar,Chandigarh,Chandigarh,160002

FAX :91-0172-2652242

Background

Incorporation Year1986

Face Value₹2

Market Lot1

How to buy Ind-Swift shares on nse?

To buy Ind-Swift shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ind-Swift share price today?

The Ind-Swift shares price on nse is Rs.24.46 today.

What is the market cap of Ind-Swift shares on BSE ?

The company has a market capitalization of Rs.135.14Cr

What is the PE & PB ratio of Ind-Swift shares ?

PE is 0 and PB is -0.19

What is the 52 Week High and Low of Ind-Swift shares?

Ind-Swift stock price high: Rs.31.09 Ind-Swift stock price low: Rs.7.75